Mursla

Cambridge, Massachusetts, United States

Diagnostics Biotech Clinical Diagnostics Biomarker Monitoring

Mursla Bio is a precision medicine and diagnostics company specializing in multi-omics exosome characterization. They develop second-generation liquid biopsy tests using tissue-specific extracellular vesicles (TS-EVs) isolated from blood. Their flagship product, EvoLiver™, detects liver cancer early in high-risk populations. Leveraging an AI Precision Medicine Platform, Mursla combines genomics, proteomics, and machine learning to provide tissue-resolved insights without invasive biopsies. They partner with pharmaceutical companies and healthcare providers to advance biomarker-guided therapies and clinical surveillance.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Mursla on @MedStartr Today #DiseaseManagement #EarlyDiseaseDetection #Diagnostics #Biotech #ClinicalDiagnostics #BiomarkerMonitoring #MedMo #MedStartrVentures

https://www.medstartr.ai/s/us5N_ODNL3w

Get Involved in Mursla

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: mursla.com/

Disease Areas

Disease Management Early Disease Detection

Technologies

Multi-OmicsLiquid BiopsyMolecular DiagnosticsBiomarker Analysis

🌐Website

What do you think of Mursla?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.